Der Schlaganfall ist eine der häufigsten und volkswirtschaftlich eine der teuersten Krankheiten.
Dennoch ist der Kenntnisstand über den Schlaganfall viel geringer ausgeprägt als für …

Anticoagulation is the cornerstone of prevention and treatment of venous thromboembolism
(VTE) and stroke prevention in patients with atrial fibrillation (AF). However, the mechanisms …

Der Schlaganfall ist eine der häufigsten und volkswirtschaftlich eine der teuersten Krankheiten.
Der Schlaganfall ist in großen neurologischen Kliniken die häufigste Krankheit. Bis zu 50…

The current manuscript is an update of the original Practical Guide, published in June 2013[Heidbuchel
H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European Heart …

Background Limited data are available on the characteristics, clinical management, and
outcomes of patients with atrial fibrillation at risk of stroke, from a worldwide perspective. The …

Background The aim of the Safe Implementation of Thrombolysis in Stroke-Monitoring Study
(SITS-MOST) was to assess the safety and efficacy of intravenous alteplase as thrombolytic …

Background Thrombolysis for acute ischaemic stroke has been investigated in several
clinical trials, with variable results. We have assessed the safety and efficacy of intravenous …

Background and Purpose— Data on risk factors for etiologic subtypes of ischemic stroke are
still scant. The aim of this study was to characterize stroke subtypes regarding risk factor …

Background The use of warfarin reduces the rate of ischemic stroke in patients with atrial
fibrillation but requires frequent monitoring and dose adjustment. Rivaroxaban, an oral factor …

Background Intravenous thrombolysis with alteplase is the only approved treatment for acute
ischemic stroke, but its efficacy and safety when administered more than 3 hours after the …